rs1057520042
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.924G>A(p.Trp308*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000455.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.924G>A | p.Trp308* | stop_gained | Exon 8 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.924G>A | p.Trp308* | stop_gained | Exon 8 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.2191G>A | non_coding_transcript_exon_variant | Exon 9 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.924G>A | p.Trp308* | stop_gained | Exon 8 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.924G>A | p.Trp308* | stop_gained | Exon 8 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.552G>A | p.Trp184* | stop_gained | Exon 10 of 12 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W308* pathogenic mutation (also known as c.924G>A), located in coding exon 8 of the STK11 gene, results from a G to A substitution at nucleotide position 924. This changes the amino acid from a tryptophan to a stop codon within coding exon 8. This mutation has been reported in several individuals with clinical diagnoses or features of Peutz-Jeghers syndrome (PJS) (Resta N et al. Dig Liver Dis, 2013 Jul;45:606-11; Jiang YL et al. BMC Med Genet, 2018 Aug;19:141; Liu Q et al. Diagn Pathol, 2022 Dec;17:96). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Peutz-Jeghers syndrome Pathogenic:1
The following ACMG criteria was used: PVS1; PM2_SUP; PS4_SUP -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.